Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/15/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Mark McKeage?

Mark J. McKeage

Associate Professor

University of Auckland

HQ Phone:  +64 9-470 1000

Email: m***@***.nz

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

University of Auckland

22 Princes Street Private Bag 92019

Auckland, Auckland,1000

New Zealand

Find other employees at this company (7,037)

Background Information

Employment History

Consultant

Novartis AG


Researcher

Oncologist and Auckland University


Lead Investigator Associate Professor

Waikato Hospital


Affiliations

ClinicaSpace Company

Scientific Advisor


Education

M.D.


MBChB MMedSc PhD

University of Auckland


Web References(55 Total References)


Associate Investigators | Maurice Wilkins Centre

www.mauricewilkinscentre.org [cached]

Associate Professor Mark McKeage
Department of Pharmacology - The University of Auckland


Associate Investigators | Maurice Wilkins Centre

www.mauricewilkinscentre.org [cached]

Associate Professor Mark McKeage
Department of Pharmacology - The University of Auckland


OncoMed Presents Phase 1b Data for First-in-Class Treatments in Ovarian, Breast and Lung Cancer at the 2016 ASCO Annual Meeting (None:OMED)

www.oncomed.com [cached]

Demcizumab: Poster Discussion (Abstract #9023): A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab, Pemetrexed and Carboplatin in Patients with 1st Line Non-Squamous Non-Small Cell Lung Cancer; Dr. Mark McKeage of University of Auckland
Trial Design


www.digitalproducer.com

"Through the current Phase 1b study in NSCLC and prior Phase 1 trials of demcizumab we have learned much about its safety and anti-tumor properties," said Mark McKeage, MBChB, MMedSc, Ph.D., FRACP, University of Auckland.
Presenting author: Mark McKeage, MBChB, MMedSc, Ph.D., FRACP, University of Auckland


Editorial Team - Journal of Thoracic Disease

www.jthoracdis.com [cached]

Mark J. McKeage, MD
Department of Pharmacology and Clinical Pharmacology, The University of Auckland, Auckland, New Zealand


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory